Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
DIAZEPAM (UNII: Q3JTX2Q7TU) (DIAZEPAM - UNII:Q3JTX2Q7TU)
Hikma Pharmaceuticals USA Inc.
DIAZEPAM
DIAZEPAM 5 mg in 5 mL
ORAL
PRESCRIPTION DRUG
Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stiff-man syndrome. Oral diazepam may be used adjunctively in convulsive disorders, although it has not proved useful as the sole therapy. The effectiveness of diazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug
Diazepam Intensol™ Oral Solution (Concentrate) The 25 mg per 5 mL (5 mg/mL) oral solution (concentrate) is supplied as a clear, yellow solution. NDC 0054-3185-44: Bottle of 30 mL with calibrated oral syringe [graduations of 0.1 mL (0.5 mg), 0.2 mL (1 mg), 0.3 mL (1.5 mg), 0.4 mL (2 mg), 0.5 mL (2.5 mg), 0.6 mL (3 mg), 0.7 mL (3.5 mg), 0.8 mL (4 mg), 0.9 mL (4.5 mg) and 1 mL (5 mg) on the oral syringe.] Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Discard opened bottle after 90 days. PROTECT FROM LIGHT. Distributed by: Hikma Pharmaceuticals USA Inc. Berkeley Heights, NJ 07922 C50000471/01 Revised November 2022
Abbreviated New Drug Application
Hikma Pharmaceuticals USA Inc. ---------- MEDICATION GUIDE MEDICATION GUIDE Diazepam Intensol™ Oral Solution (Concentrate), CIV 25 mg/ 5 mL (5 mg/mL) (dye az’ e pam) What is the most important information I should know about Diazepam IntensolTM Oral Solution? • Diazepam IntensolTMOral Solution is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system depressants (CNS) (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma and death. Get emergency help right away if any of the following happens: o shallow or slowed breathing o breathing stops (which may lead to the heart stopping) o excessive sleepiness (sedation) Do not drive or operate heavy machinery until you know how taking Diazepam IntensolTM Oral Solution with opioids affects you. • Risk of abuse, misuse, and addiction. There is a risk of abuse, misuse, and addiction with benzodiazepines, including Diazepam IntensolTM Oral Solution, which can lead to overdose and serious side effects including coma and death. o Serious side effects including coma and death have happened in people who have abused or misused benzodiazepines, including Diazepam IntensolTM Oral Solution. These serious side effects may also include delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing. Call your healthcare provider or go to the nearest hospital emergency room right away if you get any of these serious side effects. o You can develop an addiction even if you take Diazepam IntensolTM Oral Solution exactly as prescribed by your healthcare provider. o Take Diazepam IntensolTM Oral Solution exactly as your healthcare provider prescribed. o Do not share your Diazepam IntensolTM Oral Solution with other people. o Keep Diazepam IntensolTM Oral Solutionin a safe place and away from children. • Physical dependence and withdrawal reactions. Diazepam IntensolTM Oral Solution can cause physical dependence and withdrawal reactions, especially if Lugege kogu dokumenti
DIAZEPAM INTENSOL- DIAZEPAM INTENSOL SOLUTION, CONCENTRATE HIKMA PHARMACEUTICALS USA INC. ---------- DIAZEPAM _INTENSOL_™ ORAL SOLUTION (CONCENTRATE), CIV 25 MG PER 5 ML (5 MG/ML) RX ONLY WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; AND DEPENDENCE AND WITHDRAWAL REACTIONS CONCOMITANT USE OF BENZODIAZEPINES AND OPIOIDS MAY RESULT IN PROFOUND SEDATION, RESPIRATORY DEPRESSION, COMA, AND DEATH. RESERVE CONCOMITANT PRESCRIBING OF THESE DRUGS IN PATIENTS FOR WHOM ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE. LIMIT DOSAGES AND DURATIONS TO THE MINIMUM REQUIRED. • • • DESCRIPTION Each mL of Diazepam _Intensol_ Oral Solution (Concentrate) contains: diazepam, USP.........................................................5 mg alcohol......................................................................19% _Inactive Ingredients_ FOLLOW PATIENTSFOR SIGNS AND SYMPTOMS OF RESPIRATORY DEPRESSION AND SEDATION (SEE WARNINGS AND PRECAUTIONS). THE USE OF BENZODIAZEPINES, INCLUDING DIAZEPAM, EXPOSES USERS TO RISKS OF ABUSE, MISUSE, AND ADDICTION, WHICH CAN LEAD TO OVERDOSE OR DEATH. ABUSE AND MISUSE OF BENZODIAZEPINES COMMONLY INVOLVE CONCOMITANT USE OF OTHER MEDICATIONS, ALCOHOL, AND/OR ILLICIT SUBSTANCES, WHICH IS ASSOCIATED WITH AN INCREASED FREQUENCY OF SERIOUS ADVERSE OUTCOMES. BEFORE PRESCRIBING DIAZEPAM AND THROUGHOUT TREATMENT, ASSESS EACH PATIENT’S RISK FOR ABUSE, MISUSE, AND ADDICTION (SEE WARNINGS). THE CONTINUED USE OF BENZODIAZEPINES, INCLUDING DIAZEPAM, MAY LEAD TO CLINICALLY SIGNIFICANT PHYSICAL DEPENDENCE. THE RISKS OF DEPENDENCE AND WITHDRAWAL INCREASE WITH LONGER TREATMENT DURATION AND HIGHER DAILY DOSE. ABRUPT DISCONTINUATION OR RAPID DOSAGE REDUCTION OF DIAZEPAM AFTER CONTINUED USE MAY PRECIPITATE ACUTE WITHDRAWAL REACTIONS, WHICH CAN BE LIFE-THREATENING. TO REDUCE THE RISK OF WITHDRAWAL REACTIONS, USE A GRADUAL TAPER TO DISCONTINUE DIAZEPAM OR REDUCE THE DOSAGE (SEE DOSAGE AND ADMINISTRATION AND WARNINGS). TM alcohol, D&C Yellow No. 10, polyethylene glycol, propylene gly Lugege kogu dokumenti